6,902.22
0.00
(0.00%)
At close: October 9 at 9:10:50 AM CST
Research Analysis
Earnings Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | -- | -- | -- | -- |
| Avg. Estimate | 0 | 0 | 0 | 0 |
| Low Estimate | 0 | 0 | 0 | 0 |
| High Estimate | 0 | 0 | 0 | 0 |
| Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 11 | 5 | 14 | 14 |
| Avg. Estimate | 738.37M | 751.72M | 2.88B | 3.18B |
| Low Estimate | 685.8M | 734M | 2.83B | 2.85B |
| High Estimate | 798.5M | 759.5M | 2.94B | 3.4B |
| Year Ago Sales | 614.7M | 677.7M | 2.33B | 2.88B |
| Sales Growth (year/est) | 20.12% | 10.92% | 23.65% | 10.48% |
EPS Trend
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | 0 | 0 | 0 | 0 |
| 7 Days Ago | 0 | 0 | 0 | 0 |
| 30 Days Ago | 0 | 0 | 0 | 0 |
| 60 Days Ago | 0 | 0 | 0 | 0 |
| 90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
| Currency in USD | Current Qtr. (Dec 2024) | Next Qtr. (Mar 2025) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| Current Qtr. | Next Qtr. | Current Year | Next Year | |
|---|---|---|---|---|
| UTHR.MX | -- | -- | -- | -- |
| S&P 500 | 10.32% | 10.05% | 13.98% | 13.74% |
Upgrades & Downgrades
| Maintains | UBS: Buy to Buy | 1/8/2025 |
| Maintains | Goldman Sachs: Neutral to Neutral | 11/1/2024 |
| Maintains | Ladenburg Thalmann: Buy to Buy | 10/31/2024 |
| Maintains | Oppenheimer: Outperform to Outperform | 10/31/2024 |
| Maintains | Argus Research: Buy to Buy | 10/31/2024 |
| Maintains | HC Wainwright & Co.: Buy to Buy | 10/31/2024 |